Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Siplizumab

EU orphan designation number: EU/3/06/383
Active ingredient: Siplizumab
Indication: Treatment of T-cell and NK-cell neoplasms
Sponsor: MedImmune, LLC
Lagelandseweg 78, NL-6545 CG Nijmegen, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/07/2006 Centralised Orphan - Designation EMEA/OD/012/06 (2006)3094 of 29/06/2006
15/10/2009 Other procedure
13/03/2013 Centralised Orphan - Removal of orphan designation from Community Register